| Financial Year |
March 31 2023 |
| Monetary Funds |
579,532,292.62 |
| Held-for-trading Financial Assets |
841,835,014.80 |
| Notes Receivable |
-- |
| Accounts Receivable |
205,151,166.47 |
| Advances to Suppliers |
17,217,606.34 |
| Other Receivables |
63,443,825.54 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
722,052,784.22 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
293,426,464.96 |
| Total Current Assets |
2,722,659,154.95 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,199,885,081.53 |
| Under-construction Projects |
3,488,705.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
97,235,033.05 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
51,361,461.70 |
| Deferred Income Tax Assets |
50,715,333.29 |
| Other Non-Current Assets |
365,661,231.27 |
| Sub-Total of Non-Current Assets |
1,958,955,939.78 |
| Total Assets |
4,681,615,094.73 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
71,078,578.06 |
| Accounts Payable |
205,838,686.54 |
| Accounts Received In Advance |
7,267,643.88 |
| Employee Compensation Payable |
58,081,153.93 |
| Taxes Payable |
107,357,139.65 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
121,990,393.55 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
87,356,809.86 |
| Other Current Liabilities |
1,719,329.94 |
| Sub-Total of Current Liabilities |
695,790,807.90 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
105,997,380.32 |
| Total Liabilities |
801,788,188.22 |
| Paid-In Capital(Or Share Stock) |
827,591,804.00 |
| Capital Surplus |
47,577,421.67 |
| Surplus Reserve |
277,328,171.95 |
| LESS:Treasury Stock |
16,136,483.63 |
| Undistributed Profits |
2,743,465,992.52 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,879,826,906.51 |
| Owner's Equity（Stockholder's Equity） |
3,879,826,906.51 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,681,615,094.73 |
